KRAMMER F, Margine I, Hai R, Flood A, et al. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J Virol. 2013 Dec 4
The recent outbreak of H7N9 influenza virus infections in humans in China has raised concerns about the pandemic potential of this strain. Here we test the efficacy of H3-stalk based chimeric hemagglutinin universal influenza virus vaccine constructs to protect against H7N9 challenge in mice. Chimeric hemagglutinin constructs protected from viral challenge in the context of different administration routes, and a generic oil-in-water adjuvant similar to formulations licensed for use in humans.
See Also:
Latest articles in those days:
- Mapping Genetic Markers Associated with Antigenicity and Host Range in H9N2 Influenza A Viruses Infecting Poultry in Pakistan 16 hours ago
- Wastewater-based surveillance is an efficient monitoring tool for tracking influenza A in the community 16 hours ago
- Iceland: an underestimated hub for the spread of high-pathogenicity avian influenza viruses in the North Atlantic 16 hours ago
- Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker 1 days ago
- [preprint] Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle 2 days ago
[Go Top] [Close Window]